XML 67 R50.htm IDEA: XBRL DOCUMENT v3.24.0.1
Business Combination - Intangible Assets Acquired (Details) - Antares Pharma, Inc - USD ($)
$ in Thousands
7 Months Ended
Dec. 31, 2022
Dec. 31, 2023
Business Acquisition [Line Items]    
Fair value of intangible assets acquired $ 589,800 $ 589,800
ATRS-1902 (IPR&D)    
Business Acquisition [Line Items]    
Indefinite-lived intangible assets acquired 48,700  
Auto-Injector technology platform    
Business Acquisition [Line Items]    
Finite-lived intangible assets acquired 402,000  
Useful life (years)   7 years
XYOSTED proprietary product    
Business Acquisition [Line Items]    
Finite-lived intangible assets acquired 136,200  
Useful life (years)   10 years
TLANDO product rights    
Business Acquisition [Line Items]    
Finite-lived intangible assets acquired $ 2,900  
Useful life (years)   10 years